Home / News & Events
Research Highlight

Op-ed: Glycomics research supports a cure for Type 2 diabetes from plants

GlycoNet scientists at UBC have found a plant compound that helps control blood sugar levels in people with Type 2 diabetes.

Dr. Mariela Segura

Carbohydrate research in animal health supports Canadian economy

GlycoNet scientist Mariela Segura is developing glycomics-based solutions to improve livestock health.

GlycoNet start-up GlyCa Biosciences Inc. and Huron Innovation Inc. partner to improve prostate cancer detection

This partnership will launch the clinical trial of a new blood test to perfect early detection and diagnosis of clinically significant prostate cancer.

More stories

  • All
  • Awards
  • Community
  • Network Profile
  • Press Release
  • Research Highlight

BioLab Business Magazine profile: GlycoNet facilitating glycomics research collaboration and innovation

A network serving the field of glycomics research provides a platform for connections and funding

A new research chair for dementia-causing diseases in children

Thanks to a large donation and the work of GlycoNet researcher and UdeM biochemist Alexey Pshezhetsky, the Elisa Linton Research Chair in Lysosomal Diseases will help treat Sanfilippo disease and similar genetic syndromes.

GlycoNet and Partners Invest $6.5 Million in Carbohydrate Research with One Health Focus

This investment will support state-of-the-art glycomics research that focuses on different aspects of One Health—human, animal and environmental health.

GlycoNet welcomes three new members to the Board of Directors

Janice Bailey, Jason Acker and Louise St-Onge have joined the GlycoNet Board of Directors

Tiny antibodies could help treat an aggressive type of breast cancer

GlycoNet researchers have developed specialized nanobodies that could enable the immune system to fight triple-negative breast cancer more effectively.

Nobel Prize in Chemistry shines light on glycomics

Congratulations to Drs. Carolyn Bertozzi and Morten Meldal whose groundbreaking work has opened doors in glycomics innovation.

GlycoNet Integrated Services awarded $10.68 million investment from the Canadian Foundation for Innovation’s Major Science Initiative Fund

Glycomics in Canada receives crucial funding boost to further life-saving research and biotechnology development.

GlycoNet researchers develop new chemical biological tools to monitor Parkinson’s disease

Researchers are a step closer to understanding how Parkinson’s disease develops and progresses.

GlycoNet startup, ABOzymes, completes seed financing round to fund development of technology to enable universal organ transplants and blood transfusions

Glycomics is an integral part of ABOzymes’ life-saving research and technology development.

Canadian Glycomics Network
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
Tel: 780-492-6204
Fax: 780-492-4147

Subscribe to GlycoNet’s Newsletter


Scroll to Top